Abstract

BackgroundThe new 2010 ACR/EULAR classification criteria for rheumatoid arthritis (RA) have shown good diagnostic properties in early arthritis cohorts, but it is not well known how the population of early...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB0407 HIGH REMISSION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS USING BIOLOGICS UNDER A TREAT TO TARGET STRATEGY AND A COMPREHENSIVE DISEASE-MANAGEMENT MODEL. FIVE YEAR FOLLOW-UP RESULTS FROM A REAL-LIFE SETTING
Michael Cabrera ... Pedro Santos-Moreno
-
Michael Cabrera, et. al.Michael Cabrera ... Pedro Santos-Moreno
01 Jun 2019
AB0320 Patient-assessed disease activity score (PDAS) corresponds to standard disease statuses and response criteria defined by disease activity score 28 (DAS28) and clinical disease activity index (CDAI)
M.-H.A Leung ... D Farewell
Annals of the Rheumatic Diseases | VOL. 71
M.-H.A Leung, et. al.M.-H.A Leung ... D Farewell
01 Jun 2013
Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients
Farideh Alasti ... Josef S Smolen
Annals of the Rheumatic Diseases | VOL. 72
Farideh Alasti, et. al.Farideh Alasti ... Josef S Smolen
21 Aug 2012
AB0445 REMARKABLE OUTCOMES IN PATIENTS WITH RA USING CONVENTIONAL DMARDS UNDER A T2T STRATEGY AND A DISEASE MANAGEMENT MODEL – RESULTS FROM A FIVE YEAR REAL-WORLD REGISTRY
Edwin Castillo ... Danny Gomez
-
Edwin Castillo, et. al.Edwin Castillo ... Danny Gomez
01 Jun 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations
Myrto Kostopoulou ... Antonis Fanouriakis
Annals of the Rheumatic Diseases | VOL. -
Myrto Kostopoulou, et. al.Myrto Kostopoulou ... Antonis Fanouriakis
22 May 2024
View more papers